Lymphoid Aggregates That Resemble Tertiary Lymphoid Organs Define a Specific Pathological Subset in Metal-on-Metal Hip Replacements

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Mittal, Saloni ^a,b   Revell, Matthew ^b   Barone, Francesca ^a   Hardie, Debbie L ^a   Matharu, Gulraj S ^b   Davenport, Alison J ^a   Martin, Richard A ^c   Grant, Melissa ^a   Mosselmans, Frederick ^d   Pynsent, Paul ^b   Sumathi, Vaiyapuri P ^b   Addison, Owen ^a   Revell, Peter A ^b   Buckley, Christopher D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

^d DIAMOND LIGHT SOURCE LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CXCL13 CHEMOKINE; GLYCOPROTEIN; PERIPHERAL NODE ADRESIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ARTICLE; B CELL PERCENTAGE; B LYMPHOCYTE ACTIVATION; CELL AGGREGATION; CELL SURVIVAL; CONTROLLED STUDY; FOLLICULAR DENDRITIC CELL; FOREIGN BODY REACTION; HIP ARTHROPLASTY; HIP PROSTHESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LYMPHOCYTE COUNT; LYMPHOCYTE DOMINATED VASCULITIS ASSOCIATED LESION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; LYMPHOID AGGREGATION; LYMPHOID ORGAN; MAJOR CLINICAL STUDY; MECHANICAL STRESS; PROTEIN EXPRESSION; T CELL PERCENTAGE; X RAY FLUORESCENCE;

B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CCL21; CHEMOKINE CXCL13; ENDOTHELIAL CELLS; HIP JOINT; HIP PROSTHESIS; HUMANS; IONS; LYMPH NODES; METAL-ON-METAL JOINT PROSTHESES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; VENULES;

EID: 84878393933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063470     Document Type: Article

References (50)

1. Learmonth ID, Young C, Rorabeck C, (2007) The operation of the century: total hip replacement. Lancet 370: 1508-1519.
2. Revell PA (2008) Biological causes of prosthetic joint failure. Joint replacement technology: Cambridge: Woodhead. 349-396.
3. Daniel J, Pynsent PB, McMinn DJ, (2004) Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis. The Journal of bone and joint surgery British volume 86: 177-184.
4. Treacy RB, McBryde CW, Pynsent PB, (2005) Birmingham hip resurfacing arthroplasty. A minimum follow-up of five years. The Journal of bone and joint surgery British volume 87: 167-170.
5. Beaule PE, Le Duff M, Campbell P, Dorey FJ, Park SH, et al. (2004) Metal-on-metal surface arthroplasty with a cemented femoral component: a 7-10 year follow-up study. The Journal of arthroplasty 19: 17-22.
6. Revell PA, (2008) The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface 5: 1263-1278.
7. Willert HG, Buchhorn GH, Fayyazi A, Flury R, Windler M, et al. (2005) Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study. The Journal of bone and joint surgery American volume 87: 28-36.
8. Pandit H, Glyn-Jones S, McLardy-Smith P, Gundle R, Whitwell D, et al. (2008) Pseudotumours associated with metal-on-metal hip resurfacings. The Journal of bone and joint surgery British volume 90: 847-851.
9. Langton DJ, Joyce TJ, Jameson SS, Lord J, Van Orsouw M, et al. (2011) Adverse reaction to metal debris following hip resurfacing: the influence of component type, orientation and volumetric wear. The Journal of bone and joint surgery British volume 93: 164-171.
10. Campbell P, Ebramzadeh E, Nelson S, Takamura K, De Smet K, et al. (2010) Histological features of pseudotumor-like tissues from metal-on-metal hips. Clinical orthopaedics and related research 468: 2321-2327.
11. Haddad FS, Thakrar RR, Hart AJ, Skinner JA, Nargol AV, et al. (2011) Metal-on-metal bearings: the evidence so far. J Bone Joint Surg Br 93: 572-579.
12. Grammatopolous G, Pandit H, Kwon YM, Gundle R, McLardy-Smith P, et al. (2009) Hip resurfacings revised for inflammatory pseudotumour have a poor outcome. J Bone Joint Surg Br 91: 1019-1024.
13. Murray DW, Grammatopoulos G, Gundle R, Gibbons CL, Whitwell D, et al. (2011) Hip resurfacing and pseudotumour. Hip Int 21: 279-283.
14. Korovessis P, Petsinis G, Repanti M, Repantis T, (2006) Metallosis after contemporary metal-on-metal total hip arthroplasty. Five to nine-year follow-up. J Bone Joint Surg Am 88: 1183-1191.
15. Hallab N, Merritt K, Jacobs JJ, (2001) Metal sensitivity in patients with orthopaedic implants. J Bone Joint Surg Am 83-A: 428-436.
16. Kwon YM, Thomas P, Summer B, Pandit H, Taylor A, et al. (2010) Lymphocyte proliferation responses in patients with pseudotumors following metal-on-metal hip resurfacing arthroplasty. J Orthop Res 28: 444-450.
17. Natu S, Sidaginamale RP, Gandhi J, Langton DJ, Nargol AV, (2012) Adverse reactions to metal debris: histopathological features of periprosthetic soft tissue reactions seen in association with failed metal on metal hip arthroplasties. J Clin Pathol 65: 409-418.
18. Fang CS, Harvie P, Gibbons CL, Whitwell D, Athanasou NA, et al. (2008) The imaging spectrum of peri-articular inflammatory masses following metal-on-metal hip resurfacing. Skeletal Radiol 37: 715-722.
19. Glyn-Jones S, Pandit H, Kwon YM, Doll H, Gill HS, et al. (2009) Risk factors for inflammatory pseudotumour formation following hip resurfacing. J Bone Joint Surg Br 91: 1566-1574.
20. Lohmann CH, Nuechtern JV, Willert HG, Junk-Jantsch S, Ruether W, et al. (2007) Hypersensitivity reactions in total hip arthroplasty. Orthopedics 30: 760-761.
21. Mahendra G, Pandit H, Kliskey K, Murray D, Gill HS, et al. (2009) Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties. Acta Orthop 80: 653-659.
22. Pandit H, Vlychou M, Whitwell D, Crook D, Luqmani R, et al. (2008) Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: evidence for a type IV immune response. Virchows Arch 453: 529-534.
23. Aloisi F, Pujol-Borrell R, (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6: 205-217.
24. Manzo A, Paoletti S, Carulli M, Blades MC, Barone F, et al. (2005) Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis. Eur J Immunol 35: 1347-1359.
25. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, et al. (2001) Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167: 1072-1080.
26. Weyand CM, Goronzy JJ, (2003) Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 987: 140-149.
27. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, et al. (2001) Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis Rheum 44: 2633-2641.
28. Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, et al. (2005) Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum 52: 1773-1784.
29. Armengol MP, Cardoso-Schmidt CB, Fernandez M, Ferrer X, Pujol-Borrell R, et al. (2003) Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4+ T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. J Immunol 170: 6320-6328.
30. Pollard RP, Pijpe J, Bootsma H, Spijkervet FK, Kluin PM, et al. (2011) Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study. J Rheumatol 38: 2198-2208.
31. Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, et al. (2010) Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J Immunol 185: 3359-3368.
32. Bombardieri M, Barone F, Humby F, Kelly S, McGurk M, et al. (2007) Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren's syndrome. J Immunol 179: 4929-4938.
33. Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, et al. (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6: e1.
34. Solé VA, Papillon E, Cotte M, Walter P, Susini J, (2007) A multiplatform code for the analysis of energy-dispersive X-ray fluorescence spectra. Spectrochimica Acta Part B: Atomic Spectroscopy 62: 63-68.
35. Springer TA, (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
36. Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, et al. (2002) Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol 169: 424-433.
37. Mebius RE, (2003) Organogenesis of lymphoid tissues. Nat Rev Immunol 3: 292-303.
38. He B, Xu W, Santini PA, Polydorides AD, Chiu A, et al. (2007) Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26: 812-826.
39. Mackay F, Schneider P, (2009) Cracking the BAFF code. Nat Rev Immunol 9: 491-502.
40. Davies AP, Willert HG, Campbell PA, Learmonth ID, Case CP, (2005) An unusual lymphocytic perivascular infiltration in tissues around contemporary metal-on-metal joint replacements. J Bone Joint Surg Am 87: 18-27.
41. Buckley CD, Pilling D, Lord JM, Akbar AN, Scheel-Toellner D, et al. (2001) Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 22: 199-204.
42. Link A, Hardie DL, Favre S, Britschgi MR, Adams DH, et al. (2011) Association of T-zone reticular networks and conduits with ectopic lymphoid tissues in mice and humans. Am J Pathol 178: 1662-1675.
43. Marsee DK, Pinkus GS, Hornick JL, (2009) Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morphol 17: 102-107.
44. Tarlinton D, (1998) Germinal centers: getting there is half the fun. Curr Biol 8: R753-756.
45. Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, et al. (2012) Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 150: 194-206.
46. Mebius RE, Streeter PR, Breve J, Duijvestijn AM, Kraal G, (1991) The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol 115: 85-95.
47. Gregorio A, Gambini C, Gerloni V, Parafioriti A, Sormani MP, et al. (2007) Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) 46: 308-313.
48. Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, et al. (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome. Arthritis Rheum 48: 3187-3201.
49. Hart AJ, Quinn PD, Lali F, Sampson B, Skinner JA, et al. (2012) Cobalt from metal-on-metal hip replacements may be the clinically relevant active agent responsible for periprosthetic tissue reactions. Acta Biomater 8: 3865-3873.
50. Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM, (2001) T cell activation in rheumatoid synovium is B cell dependent. J Immunol 167: 4710-4718.